Lupvindol Biosciences

Oceanside, United States

Lupvindol Biosciences is a biotechnology company that treats autoimmune and inflammatory conditions affecting both humans and animals.

$2.2M raised

Dec 2024

Seed

Biotechnology Manufacturing Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lupvindol Biosciences

How much funding has Lupvindol Biosciences raised?

Lupvindol Biosciences has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in December 2024.

Where is Lupvindol Biosciences headquartered?

Lupvindol Biosciences is headquartered in Oceanside, United States.

What does Lupvindol Biosciences do?

Lupvindol Biosciences is a biotechnology company that treats autoimmune and inflammatory conditions affecting both humans and animals.

What stage is Lupvindol Biosciences at?

Lupvindol Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 23, 2024.

MLA

"Lupvindol Biosciences — Funding & Investors." VCBacked, December 23, 2024, https://www.vcbacked.co/company/lupvindol-biosciences. Accessed July 5, 2026.

APA

VCBacked. (2024). Lupvindol Biosciences — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/lupvindol-biosciences

Wikipedia (cite web)

{{cite web |title=Lupvindol Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/lupvindol-biosciences |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 23, 2024.